Metraipolis › archive › dc_8f50fa9070fd

Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of… — Europe PMC PMID:37449993

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37449993
DOI
10.1007/s00228-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-10-07T20:44:01.459Z
SHA-256 of the archived text
5086b6ae55d82816da7b985cb4d4f197a8b145c6e68e49b8d8e0d254d065560f
Stable URL of this page
https://metraipolis.com/documento/dc_8f50fa9070fd

How to cite

Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of… — Europe PMC PMID:37449993 — Europe PMC (en), https://europepmc.org/article/MED/37449993 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8f50fa9070fd (Metraipolis archive dc_8f50fa9070fd, sha256 5086b6ae55d82816da7b985cb4d4f197a8b145c6e68e49b8d8e0d254d065560f)
BibTeX
@misc{dc8f50fa9070fd,
  title = {Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of… — Europe PMC PMID:37449993},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37449993},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8f50fa9070fd; sha256 5086b6ae55d82816da7b985cb4d4f197a8b145c6e68e49b8d8e0d254d065560f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37449993. Agents can read the archived copy with the MCP tool read_document.